In this Issue
Plus: Access & Closure
Chief Medical Editor’s Page
By Ted E. Feldman, MD, MSCAI, FACC, FESC
A look back at the long road to FDA approval and the implications on patient care options going forward.
By Marie-France Poulin, MD; and Clifford J. Kavinsky, MD, PhD
A closer look at current technology as the indications for PFO closure become clearer.
By Narbeh Melikian, BSc, MB BS, MD, FRCP; and Philip A. MacCarthy, BSc, MB BCh, PhD, FRCP
Considerations when choosing an oral anticoagulant, antiplatelet therapy, or closure device for recurrent cryptogenic stroke prevention when a PFO is present.
By Toby Rogers, MD, PhD
The roles of TEE and CTA in anatomic assessment and device selection for LAA closure.
By Dee Dee Wang, MD; and Marvin H. Eng, MD
Current indications for antiplatelet agents and NOACs after Watchman implantation.
By Mathieu Lempereur, MD; and Adel Aminian, MD
By Paul J. Pearson, MD, PhD; and D. Craig Miller, MD
ACCESS & CLOSURE
Experts share their institutions’ protocols for using this technique.
By Michael H. Salinger, MD, FACC, FSCAI; Hyde M. Russell, MD; Susheel Kodali, MD; and Lowell Satler, MD
A synopsis of the techniques and technology available to assist with and improve the benefits of radial access procedures.
By Anthony Wassef, MD, FRCPC; and Asim N. Cheema, MD, PhD, FRCPC
CODING & REIMBURSEMENT
Answering questions about the shift in cardiology from inpatient to outpatient procedures.
By Anne Beekman, RN
Dr. Kar shares his insights on current left atrial appendage closure data, as well as his thoughts on transcatheter mitral and tricuspid repair.